IL6 and COVID-19: As shown in Supplementary Table 2, among the 17 patients with severe COVID-19, the six patients who died exhibited significantly higher IL-6 levels compared with those who survived (486.2 ± 424.5 pg/mL vs. 98.6 ± 176.8 pg/mL, respectively; p = .035).